Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia.
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia. / Lebech, Anne-Mette; Kristoffersen, Ulrik Sloth; Wiinberg, Niels; Kofoed, Kristian; Andersen, Ove; Hesse, Birger; Petersen, Claus Leth; Gerstoft, Jan; Kjær, Andreas; Lebech, Anne-Mette; Kristoffersen, Ulrik; Wiinberg, Niels; Kofoed, Kristian; Andersen, Ove; Hesse, Birger; Petersen, Claus; Gerstoft, Jan; Kjær, Andreas.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No. 11, 2008, p. 2049-2058.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia.
AU - Lebech, Anne-Mette
AU - Kristoffersen, Ulrik Sloth
AU - Wiinberg, Niels
AU - Kofoed, Kristian
AU - Andersen, Ove
AU - Hesse, Birger
AU - Petersen, Claus Leth
AU - Gerstoft, Jan
AU - Kjær, Andreas
AU - Lebech, Anne-Mette
AU - Kristoffersen, Ulrik
AU - Wiinberg, Niels
AU - Kofoed, Kristian
AU - Andersen, Ove
AU - Hesse, Birger
AU - Petersen, Claus
AU - Gerstoft, Jan
AU - Kjær, Andreas
PY - 2008
Y1 - 2008
N2 - BACKGROUND: The mechanisms underlying increased cardiovascular risk in HIV patients in antiretroviral therapy (ART) are not known. Our aim was to study the endothelial function of the coronary arteries by cardiac perfusion positron emission tomography (PET), in HIV patients with normal or high cholesterol levels. Flow mediated dilation (FMD) of the brachial artery and circulating endothelial markers were also assessed. METHODS AND RESULTS: HIV patients in ART with total cholesterol /= 6.5 mmol/L (254 mg/dL; n = 12) and healthy controls (n = 14) were included. (13)NH(3) perfusion PET, FMD, and measurement of plasma levels of E-Selectin, ICAM-1, VCAM-1, tPAI-1, and hs-CRP were performed. Baseline myocardial perfusion and the coronary flow reserve measured by PET (3.2 +/- 0.3, 3.2 +/- 0.3 and 3.0 +/- 0.3; ns) was similar in HIV patients with normal or high total cholesterol and controls. FMD did not differ between the groups and was 4.6 +/- 1.1%, 5.1 +/- 1.2%, and 4.6 +/- 0.8%, respectively. Increased levels of plasma E-Selectin, ICAM-1, tPAI-1, and hs-CRP were found in HIV patients when compared to controls (p < 0.05). E-Selectin and ICAM-1 levels were higher in HIV patients receiving protease inhibitors (PI) compared to those not receiving PI (p < 0.05). None of the measured endothelial biomarkers differed between the normal and high cholesterol HIV groups. CONCLUSIONS: In ART-treated HIV patients with a low overall cardiovascular risk, no sign of endothelial dysfunction was found not even in hypercholesterolemic patients. Also, the increased level of plasma endothelial markers found in HIV patients was not related to hypercholesterolemia.
AB - BACKGROUND: The mechanisms underlying increased cardiovascular risk in HIV patients in antiretroviral therapy (ART) are not known. Our aim was to study the endothelial function of the coronary arteries by cardiac perfusion positron emission tomography (PET), in HIV patients with normal or high cholesterol levels. Flow mediated dilation (FMD) of the brachial artery and circulating endothelial markers were also assessed. METHODS AND RESULTS: HIV patients in ART with total cholesterol /= 6.5 mmol/L (254 mg/dL; n = 12) and healthy controls (n = 14) were included. (13)NH(3) perfusion PET, FMD, and measurement of plasma levels of E-Selectin, ICAM-1, VCAM-1, tPAI-1, and hs-CRP were performed. Baseline myocardial perfusion and the coronary flow reserve measured by PET (3.2 +/- 0.3, 3.2 +/- 0.3 and 3.0 +/- 0.3; ns) was similar in HIV patients with normal or high total cholesterol and controls. FMD did not differ between the groups and was 4.6 +/- 1.1%, 5.1 +/- 1.2%, and 4.6 +/- 0.8%, respectively. Increased levels of plasma E-Selectin, ICAM-1, tPAI-1, and hs-CRP were found in HIV patients when compared to controls (p < 0.05). E-Selectin and ICAM-1 levels were higher in HIV patients receiving protease inhibitors (PI) compared to those not receiving PI (p < 0.05). None of the measured endothelial biomarkers differed between the normal and high cholesterol HIV groups. CONCLUSIONS: In ART-treated HIV patients with a low overall cardiovascular risk, no sign of endothelial dysfunction was found not even in hypercholesterolemic patients. Also, the increased level of plasma endothelial markers found in HIV patients was not related to hypercholesterolemia.
U2 - 10.1007/s00259-008-0846-6
DO - 10.1007/s00259-008-0846-6
M3 - Journal article
C2 - 18661131
VL - 35
SP - 2049
EP - 2058
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
SN - 1619-7070
IS - 11
ER -
ID: 8464674